IMUNON secures $10 million financing for ovarian cancer trial

Go back to IMUNON secures $10 million financing for ovarian cancer trial
(NASDAQ: IMNN) Delayed: 1.59 -0.08 (4.79%)
Previous Close $1.67    52 Week High
Open $1.70    52 Week Low
Day High $1.70    P/E N/A 
Day Low $1.55    EPS
Volume 179,328